ÍøºìºÚÁÏ

Skip to main content
(352) 273-9120

Biljana Horn, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Biljana Horn
(352) 273-9120 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Hematopoietic Stem Cell Transplantation , 34 publications
  • Graft vs Host Disease , 12 publications
  • Transplantation Conditioning , 11 publications
  • Transplantation, Homologous , 10 publications

Research activity

60 publications

1,620 citations

Why is this important?

Active clinical trials

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
1 Year - 70 Years
Sexes
All
Conditioning SCID Infants Diagnosed Early (CSIDE)

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
0 Years - 2 Years
Sexes
All

My publications

60 publications

2014

A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.

Pediatric transplantation

•

2014

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation

2014

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Blood

•

2013

131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.

Pediatric blood & cancer

•

2013

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

•